The January 2026 issue (Volume 2, Number 1) of IJPHARMDART [eISSN: 3139-1117] has been officially published, presenting a comprehensive collection of peer-reviewed scholarly articles that explore emerging trends in global healthcare markets, pharmaceutical business intelligence, artificial intelligence, healthcare facilities management, and health economics. The issue reflects the journal's continued commitment to disseminating multidisciplinary research that bridges healthcare, management, technology, and market analysis.
Comprising five insightful research articles authored by academicians, independent researchers, and postgraduate scholars, this issue provides evidence-based analyses of evolving healthcare markets and strategic innovations shaping the future of global healthcare delivery.
Comprehensive Analysis of the U.S. Health and Wellness Market
The issue opens with the research article "A Comprehensive Study of the U.S. Health and Wellness Market: Industry Trends, Consumer Perceptions, and Future Growth," authored by Mrs. Roopali Agrawal.
The study presents an extensive analysis of one of the world's fastest-growing healthcare sectors by examining market dynamics, consumer preferences, emerging wellness trends, and future growth opportunities. The article explores the increasing demand for preventive healthcare, personalized wellness solutions, digital health technologies, and lifestyle-based interventions while providing valuable insights into the evolving health and wellness ecosystem in the United States.
Market Outlook for the U.S. Antifungal Drugs Industry
Another significant contribution, "U.S. Antifungal Drugs Market: Market Analysis and Stakeholder Perceptions (2024–2030)," authored by Ms. Amey Deshpande and Dr. Ravi Agrawal, offers a detailed evaluation of the antifungal pharmaceutical market.
The article examines market growth projections, disease burden, therapeutic innovations, regulatory developments, and stakeholder perspectives influencing the antifungal drug industry. By assessing current market trends and future opportunities, the study provides valuable insights for pharmaceutical companies, healthcare professionals, investors, and policymakers involved in infectious disease management.
Pharmacy Benefit Management Market: Strategic Growth Analysis
The January issue also features "Pharmacy Benefit Management (PBM) Market Analysis: 2025–2034," authored by Mr. Kavya Prithwani and Dr. Ravi Agrawal.
The article provides a comprehensive assessment of the rapidly expanding Pharmacy Benefit Management (PBM) sector, highlighting its role in optimizing prescription drug utilization, reducing healthcare expenditure, and improving medication accessibility. The study evaluates emerging business models, technological advancements, regulatory developments, and long-term market projections expected to shape the PBM industry over the coming decade.
Global Healthcare Facilities Management in the Era of Digital Transformation
The issue further includes "Technological Integration, Outsourcing, and Sustainability in Global Healthcare Facilities Management: Trends, Challenges, and Strategic Best Practices," authored by Mr. Swapneel Panigrahi and Dr. Ravi Agrawal.
The article explores how healthcare organizations worldwide are leveraging digital technologies, outsourcing strategies, and sustainable operational practices to improve facility management and healthcare delivery. The authors discuss innovations in smart infrastructure, resource optimization, environmental sustainability, and operational efficiency while highlighting best practices that support resilient healthcare systems in an increasingly technology-driven environment.
Artificial Intelligence Continues to Transform Modern Medicine
Completing the issue is "Artificial Intelligence in Medicine Market," authored by Mr. Christopher Dalyop.
The research provides an in-depth overview of the rapidly evolving Artificial Intelligence (AI) market in healthcare, examining its applications in medical diagnostics, predictive analytics, clinical decision support, drug discovery, personalized medicine, and hospital management. The article highlights current market trends, technological advancements, investment opportunities, and future challenges while emphasizing AI's transformative role in improving healthcare quality, operational efficiency, and patient outcomes across global healthcare systems.
Driving Innovation Through Multidisciplinary Healthcare Research
The January 2026 issue demonstrates the broad academic vision of IJPHARMDART [eISSN: 3139-1117], bringing together research spanning healthcare management, pharmaceutical markets, business analytics, digital health, artificial intelligence, healthcare infrastructure, and strategic market intelligence. The featured articles collectively provide valuable scientific and managerial insights that support informed decision-making across academia, healthcare organizations, pharmaceutical industries, and policy institutions.
As an international peer-reviewed scholarly journal, IJPHARMDART [eISSN: 3139-1117] remains dedicated to publishing high-quality interdisciplinary research that advances scientific knowledge, encourages innovation, and promotes evidence-based practices across healthcare, pharmaceutical sciences, business management, and emerging technologies.
Issue Information - https://pharmdart.org/archives-details.php?fldPathId=28
- Journal: IJPHARMDART
- eISSN: 3139-1117
- Volume: 2
- Issue: 1
- Publication Month: January 2026
- Publication Date: 30 January 2026
The Editorial Board extends its sincere congratulations to all contributing authors and expresses its gratitude to reviewers, editorial members, and readers for their continued support in strengthening the journal's mission of promoting excellence in scientific publishing, interdisciplinary research, and global healthcare innovation.
.png)
0 Comments
Your comments add value to the news!!